8 Hidden Multibagger Stocks to Buy Now
Finding multibagger stocks, i.e., stocks that grow to many times their original value, is the ultimate goal of many investors.
Structure Therapeutics Inc. (GPCR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 6,555,555 | $315,977,751 | 3.11% | |
| 2. | Deep Track Capital David Kroin | 4,279,848 | $206,288,674 | +5% | 3.37% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,459,358 | $166,741,056 | -1% | 5.31% |
| 4. | Driehaus Capital Richard Driehaus | 1,577,356 | $76,028,559 | -4% | 0.56% |
| 5. | OrbiMed Advisors Samuel Isaly | 1,475,403 | $71,114,425 | +27% | 1.41% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 836 | $44,868 | 0% | |
| 2. | 20 | $1,073 | 0% |
News See All
10 Best Mid-Cap Stocks That Could Double Your Money
In this article, we will take a look at some of the best mid-cap stocks that are currently offering at least 100% upside potential to investors. On June 13, CNBC reported that U.S.
8 Oversold Stocks to Buy Right Now
On June 1, Tom Lee, Fundstrat Managing Partner & Head of Research, and Fundstrat Capital CIO, appeared on CNBC's 'Squawk Box' to discuss the latest market trends.
10 Best Biotech Stocks with Highest Upside Potential
On April 16, reports from J.P. Morgan's biopharma and medtech venture and licensing studies indicated that the capital markets began the year 2026 with selective strength.
Structure Therapeutics (GPCR) Gained from Favorable Clinical Data
Meridian Funds, managed by ArrowMark Partners, released its fourth-quarter 2025 investor letter for “Meridian Small Cap Growth Fund”. A copy of the letter can be downloaded here. U.S.
Structure Therapeutics Inc. (GPCR) Has Gained Over 130% in 3 Months. Here is Why
Structure Therapeutics Inc. (NASDAQ:GPCR) is among the 14 best booming stocks to buy right now.
14 Best Booming Stocks to Buy Right Now
In a report released on January 9, Goldman Sachs said that it expects the index to rally 12% in 2026.
7 Stocks on Jim Cramer’s Radar Recently
“The market gets so angry over nothing. It's just plain irritable, very hard to please, like a 3-year-old child. But when you make it happy, the inner child giggles, and your stocks will soar.
H.C. Wainwright Upgrades Structure Therapeutics (GPCR) on Massive Arbitrage Opportunity for Oral GLP-1
Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the best up and coming stocks to buy according to Wall Street. On December 19, H.C.
10 Best Up and Coming Stocks to Buy According to Wall Street
On December 26, Thomson Nguyen, Saga Ventures co-founder and managing partner, joined 'Squawk Box' on CNBC to discuss the resurgence of the IPO market following a strong 2025 performance.
Hedge Fund Resource Center